RxDoctor Payments Data

Sarah Ingles

Family · Port Huron, MINPI 1053323147

Payments from drug & device makers

$2,750in general payments, 2019–2025

Across 150 payments — averaging $18.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Alkermes, Inc.$666
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$522
  • Teva Pharmaceuticals USA, Inc.$364
  • Otsuka America Pharmaceutical, Inc.$249
  • Indivior Inc.$208
  • Supernus Pharmaceuticals, Inc.$135
  • plus $607 from 10 others

What the payments were for

  • Food & beverage$2,65396%
  • Education$974%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,750 in reported general payments places this provider in the 85th percentile of 3,657 family providers in Michigan.

See all family providers in Michigan

Medicare billing

Part B allowed, 2024
$25,006
Medicare patients
37
Services billed
256

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Invega SustennaPaliperidone Palmitate34$111,605
Abilify MaintenaAripiprazole13$37,512
SpravatoEsketamine Hcl25$29,475
TrintellixVortioxetine Hydrobromide25$12,943
Divalproex Sodium ErDivalproex Sodium73$5,810
QelbreeViloxazine Hcl16$5,191
Chlorpromazine Hcl26$4,360
Clozapine59$3,127
Aripiprazole114$2,884
Asenapine Maleate16$2,338
Naltrexone Hcl30$2,010
Risperidone84$1,910
Oxcarbazepine49$1,840
Quetiapine Fumarate ErQuetiapine Fumarate63$1,559
Olanzapine OdtOlanzapine12$1,376

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonInvega Sustenna, Spravato$119$141,08059 claims
Otsuka America Pharmaceutical, Inc.Abilify Maintena$249$37,51213 claims
Supernus Pharmaceuticals, Inc.Qelbree$135$5,19116 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 3,657 family providers in Michigan.

Other family in Port Huron

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →